top of page
White couple with baby ultrasound photo.jpg
PROfertil_male_Logo_FocusedPharma_Malta.png

REDUCES
DNA FRAGMENTATION

PROfertil_male_FocusedPharma_Malta.png

DNA STUDY 2021

Reduction of sperm DNA fragmentation (DFI in %) after 3 months of PROFERTIL® regimen

PROfertil_male_study1_FocusedPharma_Malta.png

  • Significantly decreases sperm DNA fragmentation compared to the control group (lifestyle change only).

PROfertil_Pillensperm-2-768x82.png
Gravidanza

  • Pregnancy rate 41.3% in PROFERTIL® Subgroup DFI > 15% vs. 22.9% in control group

  • Pregnancy rate 41.3% in PROFERTIL® Subgroup DFI > 15% vs. 22.9% in control group

  • Pregnancy rate 41.3% in PROFERTIL® Subgroup DFI > 15% vs. 22.9% in control group

  • Pregnancy rate 27.8% in PROFERTIL® group vs. 15.3% in control group (total study population)

PROfertil_male_study_FocusedPharma_Malta.png
PROfertil_male_study2_FocusedPharma_Malta.png
PROfertil_male_study3_FocusedPharma_Malta.png

Number of patients:
n = 339
(PROFERTIL®-group: n = 162;
Control group: n = 177)

DNA-Study 2021; The effect of micronutrient supplementation on spermatozoa DNA integrity in subfertile men and subsequent pregnancy rate; Lipovac M. et al.; published in Gynecological Endocrinology 2021 Jun; 37(6); patients (n = 339): PROFERTIL® group: n=162, control group n=177. 

© 2021 Focused Pharma

bottom of page